Neurology Minute

Dr. Jessica Ailani and Dr. Francesca Puledda discuss the International Headache Society's global practice recommendations for acute and preventive treatment of migraine. Show reference:  https://journals.sagepub.com/doi/10.1177/03331024241252666  https://journals.sagepub.com/doi/full/10.1177/03331024241269735  

In the third episode of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss the inspiration behind this abstract. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

In the second part of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss treatment options for LGI-1 encephalitis.  Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

In part one of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss how LGI-1 encephalitis typically presents in clinic and how to make the correct diagnosis. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html  

Dr. Dan Ackerman and Dr. Phillip Ferdinand discuss the impact smoking has on stroke risk.  Show reference: https://www.neurology.org/doi/10.1212/WN9.0000000000000003 

Dr. Gordon Smith and Dr. Timothy Miller discuss compelling clinical data suggesting that ALS may be a treatable disease for a subset of patients.

In the final part of this three-part series, Dr. Jason Crowell delves into the third issue discussed at NOH, funding for NINDS and the BRAIN Initiative. Show reference: https://www.aan.com/advocacy/ 

In the second part of this three-part series, Dr. Jason Crowell delves into the second issue discussed at NOH, emphasizing the importance of extending telehealth flexibilities. Show reference: https://www.aan.com/advocacy/ 

In the first installment of this three-part series, Dr. Jason Crowell discusses the impact cuts to the Medicare Fee Scheduler has on patient care and the field of neurology.  Show reference: https://www.aan.com/advocacy/

Dr. Trey Bateman and Dr. Amy Brodtmann discuss referrals for frontal network impairment and FTD, highlighting the most helpful information for reaching a final diagnosis after evaluation. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200360   

Dr. Tesha Monteith and Dr. Patricia Pozo-Rosich discuss the latest advancements in headache medicine, focusing on key research findings from 2024. 

Dr. Alberto Ramos discusses the importance of sleep for brain health. 

Dr. Alberto Ramos discusses how managing risk factors for sleep apnea can significantly reduce systemic vascular risks and preserve neurologic function.

Dr. Tesha Monteith discusses the Headache Journal article, “Association of Migraine Treatments with Reduced Ischemic Stroke Risk: Evidence from Two Large-Scale Real-World Data Analyses.” Show reference:  https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14918

Dr. Alison Christy and Dr. Wallace J. Brownlee discuss whether dissemination in time is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space criteria. Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000210274 

In part two of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PRESTIAGE-AF trial. Show references: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00333-2/fulltext 

In part one of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss two trials that were looking at the use of endovascular therapy for medium vessel occlusion.  Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2411668 https://www.nejm.org/doi/full/10.1056/NEJMoa2408954  

Dr. Jeff Ratliff delves into the common causes of acquired dystonia and highlights evidence-based treatment strategies for effective management.    

Dr. Jeff Ratliff provides an in-depth look at orthostatic tremor, a rare and often overlooked movement disorder, highlighting its symptoms, challenges, and the importance of early detection. Show references: https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.13454 

In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide. Show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract